CinCor Pharma, Inc. — Form D

CinCor Pharma, Inc. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-12. The offering totals $142.9M, of which $142.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-10-12
• Form: D
• Accession: 0001868734-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $142.9M
• Amount sold: $142.9M
• Investors: 22
• Date of first sale: 2021-09-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-416469

Issuer

• Name: CinCor Pharma, Inc.
• CIK: 0001868734
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 5375 MEDPACE WAY, CINCINNATI, OH, 45227
• Phone: 8445311834

Officers, directors & promoters (2)

More

• CIK 1868734 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search